Skip to main content
. 2021 Jun 4;11:649029. doi: 10.3389/fonc.2021.649029

Figure 1.

Figure 1

FHL3 is an independent risk factor in gastric cancer. (1) The expression level of FHL3 in gastric cancer and its adjacent tissues was analyzed in TCGA database, GTEx, and Beijing dataset (A–H); the results suggested that FHL3 is highly expressed in tumor tissues. (2) The relationship between FHL3 expression level and prognosis is performed by Kaplan–Meier analysis in TCGA, KM-plotter cohorts; the results suggested that FHL3 is a prognostic indicator in gastric cancer; FHL3 overexpression always means poor overall survival (I, J).